BioNTech/Pfizer/(BNT162b2)/COVID-19/MRNA/Vaccine:/Manufacturing,/Immunogenicity,/Efficacy/and/Safety. Prospect. Pharm. Sci. 2025, 23 (1), 31-46. https://doi.org/10.56782/pps.292.